We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > FoundationOne Liquid CDx

News List

FDA Approves Liquid Biopsy NGS Companion Diagnostic Test americanpharmaceuticalreview
November 20, 2020
The U.S. Food and Drug Administration (FDA) approved the liquid biopsy next-generation sequencing-based FoundationOne Liquid CDx test (Foundation Medicine, Inc.) as a companion diagnostic device for multiple additional biomarkers detected in ...
US approves Roche's new pan-tumour liquid biopsy test pharmatimes
August 28, 2020
US regulators have approved Roche's new pan-tumour liquid biopsy test for patients with solid tumours, offering a potentially more convenient option and an alternative for patients unable to have tissue biopsy.